nach oben

Erschienen in:

01.02.2015 | e-Herz: Original article

Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI

verfasst von: S. Kul, MD, H. Uyarel, O.T. Kucukdagli, M. Turfan, M.A. Vatankulu, A. Tasal, E. Erdogan, E. Asoglu, M. Sahin, T.S. Guvenc, O. Goktekin

Erschienen in: Herz | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Contrast-induced acute kidney injury (CI-AKI) is a common complication in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The Mehran risk score was defined originally in elective PCI and may be predictive of CI-AKI. The aim of the present study was to investigate whether the Zwolle score predicts CI-AKI in patients with acute STEMI undergoing primary PCI.

Patients and methods

We analyzed the data of 314 consecutive patients (mean age 56.3 ± 11.4 years) with acute STEMI undergoing primary PCI. The study population was divided into two groups according to CI-AKI development. The Mehran score, Zwolle score, baseline characteristics, and in-hospital outcomes were recorded.

Results

Patients with CI-AKI had higher Mehran and Zwolle scores. In a receiver operating characteristic (ROC) curve analysis, high area under the curve (AUC) values were determined for Zwolle and Mehran scores (0.85 and 0.79, respectively) for CI-AKI development. A Zwolle score greater than 2 predicted CI-AKI with a sensitivity of 76.3 % and a specificity of 75.4 %. A Mehran score greater than 5 predicted CI-AKI with a sensitivity of 71.1 % and a specificity of 73.6 %.

Conclusion

Zwolle score predicts CI-AKI slightly better than the Mehran score in patients with STEMI undergoing primary PCI. This simple score can be used at the catheterization laboratory for risk stratification for the development of CI-AKI.

Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264CrossRefPubMed

McCullough P (2006) Contrast induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67:335–343CrossRefPubMed

Barrett BJ, Parfrey PS (2006) Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386CrossRefPubMed

Zijlstra F, Hoorntje JCA, De Boer MJ et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413–1419CrossRefPubMed

Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785CrossRefPubMed

Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624–628CrossRefPubMed

Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast- induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399PubMed

De Luca G, Suryapranata H, Hof AW van’t et al (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743CrossRef

Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney functionmeasured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483CrossRefPubMed

10.

Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367CrossRefPubMed

11.

Chesebro JH, Knatterud G, Roberts R et al (1987) Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142–154CrossRefPubMed

12.

Mehran R, Dangas G, Abizaid AS et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878CrossRefPubMed

13.

Garg S, Serruys PW, Silber S et al (2011) The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 4(4):432–441CrossRefPubMed

14.

Bellomo R, Ronco C, Kellum JA et al (2004) Acute Dialysis Quality Initiative workgroup: acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212CrossRefPubMedPubMedCentral

15.

Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral

16.

Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344–2351CrossRefPubMed

17.

Thygesen K, Alpert JS, Jaffe AS et al (2012) Joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567CrossRefPubMed

18.

Thiele H, Hildebrand L, Schirdewahn C et al (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single- Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 55:2201–2209CrossRefPubMed

19.

Marenzi G, Assanelli E, Campodonico J et al (2010) Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 38:438–444CrossRefPubMed

20.

Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence- based approach. Circulation 113:1799–1806CrossRefPubMed

21.

Tumlin J, Stacul F, Adam A et al (2006) CIN Consensus Working Panel:pathophysiology of contrast-induced nephropathy. Am J Cardiol 98:14–20CrossRef

22.

Uyarel H, Cam N, Ergelen M et al (2009) Contrast induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction: incidence, a simple risk score, and prognosis. Arch Med Sci 5:550–558

23.

Wi J, Ko YG, Kim JS et al (2011) Impact of contrast- induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757CrossRefPubMed

24.

Briguori C, Airoldi F, D’Andrea D et al (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211–1217PubMed

25.

Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420CrossRefPubMed

26.

ACT Investigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 124:1250–1259CrossRef

27.

Kelly AM, Dwamena B, Cronin P et al (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy: Ann Intern Med 148:284–294

28.

Hsiao PG, Hsieh CA, Yeh CF et al (2012) Early prediction of acute kidney injury in patients with acute myocardial injury. J Crit Care 27:525CrossRefPubMed

29.

Perrin T, Descombes E, Cook S (2012) Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly 142:w13608PubMed

30.

Sgura FA, Bertelli L, Monopoli D et al (2010) Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST- elevationmyocardial infarction. Circ Cardiovasc Interv 3:491–498CrossRefPubMed

Titel: Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI
verfasst von: S. Kul, MD
H. Uyarel
O.T. Kucukdagli
M. Turfan
M.A. Vatankulu
A. Tasal
E. Erdogan
E. Asoglu
M. Sahin
T.S. Guvenc
O. Goktekin
Publikationsdatum: 01.02.2015
Verlag: Urban & Vogel
Erschienen in: Herz / Ausgabe 1/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-013-3957-1

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI

Abstract

Objective

Patients and methods

Results

Conclusion

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objective

Patients and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Interventionelle Therapie von paroxysmalem Vorhofflimmern

Frequenz- und Rhythmuskontrolle bei Vorhofflimmern

Early coronary vein stenosis after cardiac resynchronization therapy

Coronary spasms, cardiomyopathy, and Churg–Strauss syndrome

Delayed left ventricular-to-right atrial communication (acquired Gerbode defect) after aortic valve replacement

Katheterablation bei persistierendem Vorhofflimmern

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie